메뉴 건너뛰기




Volumn 58, Issue 7, 2011, Pages

Utility of18FDG-PET/CT in breast cancer diagnostics - a systematic review

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

EID: 79960034723     PISSN: None     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (21)

References (40)
  • 1
    • 79960043129 scopus 로고    scopus 로고
    • Cancerregisteret, Year 13, No. 2, June
    • Cancerregisteret 2007. Nye tal fra Sundhedsstyrelsen. Year 13, No. 2, June 2009.
    • (2007) Nye Tal Fra Sundhedsstyrelsen
  • 2
    • 79251471505 scopus 로고    scopus 로고
    • Dødsårsagsregistret 2002-2006, Year 12, No. 10, September
    • Dødsårsagsregistret 2002-2006. Nye tal fra Sundhedsstyrelsen. Year 12, No. 10, September 2008.
    • (2008) Nye Tal Fra Sundhedsstyrelsen
  • 3
    • 45149106940 scopus 로고    scopus 로고
    • Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry
    • Mouridsen HT, Bjerre KD, Christiansen P et al. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008;47:525-36.
    • (2008) Acta Oncol , vol.47 , pp. 525-536
    • Mouridsen, H.T.1    Bjerre, K.D.2    Christiansen, P.3
  • 4
    • 36148985779 scopus 로고    scopus 로고
    • FDG PET/CT for the detection and evaluation of breast diseases: Usefulness and limitations
    • Lim HS, Yoon W, Chung TW et al. FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. RadioGraphics 2007;27:197-213.
    • (2007) RadioGraphics , vol.27 , pp. 197-213
    • Lim, H.S.1    Yoon, W.2    Chung, T.W.3
  • 5
    • 43349102072 scopus 로고    scopus 로고
    • Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer
    • Cermik TF, Mavi A, Basu S et al. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 2008;35:475-83.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , pp. 475-483
    • Cermik, T.F.1    Mavi, A.2    Basu, S.3
  • 6
    • 0036707492 scopus 로고    scopus 로고
    • The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer
    • Danforth DN, Aloj L, Carrasquillo JA et al. The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Can Res Treatment 2002;75:135-46.
    • (2002) Breast Can Res Treatment , vol.75 , pp. 135-146
    • Danforth, D.N.1    Aloj, L.2    Carrasquillo, J.A.3
  • 7
    • 0034667846 scopus 로고    scopus 로고
    • Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations
    • Avril N, Rosé CA, Schelling M et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18:3495-502.
    • (2000) J Clin Oncol , vol.18 , pp. 3495-3502
    • Avril, N.1    Rosé, C.A.2    Schelling, M.3
  • 8
    • 0037301618 scopus 로고    scopus 로고
    • Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions
    • Heinisch M, Gallowitsch HJ, Mikosch P et al. Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions. The breast 2003;12:17-22.
    • (2003) The Breast , vol.12 , pp. 17-22
    • Heinisch, M.1    Gallowitsch, H.J.2    Mikosch, P.3
  • 9
    • 0030852417 scopus 로고    scopus 로고
    • Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours
    • Palmedo H, Bender H, Grünwald F et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nucl Med 1997;24:1138-45.
    • (1997) Eur J Nucl Med , vol.24 , pp. 1138-1145
    • Palmedo, H.1    Bender, H.2    Grünwald, F.3
  • 10
    • 0032739049 scopus 로고    scopus 로고
    • Positron emission tomography in breast cancer: A clinicopathological correlation of results
    • Rostom AY, Powe J, Kandil A et al. Positron emission tomography in breast cancer: a clinicopathological correlation of results. Br J Radiol 1999;72:1064-8.
    • (1999) Br J Radiol , vol.72 , pp. 1064-1068
    • Rostom, A.Y.1    Powe, J.2    Kandil, A.3
  • 11
    • 33746930169 scopus 로고    scopus 로고
    • Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer
    • Kumar R, Chauhan A, Zhuang H et al. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Can Res Treatment 2006;98:267-74.
    • (2006) Breast Can Res Treatment , vol.98 , pp. 267-274
    • Kumar, R.1    Chauhan, A.2    Zhuang, H.3
  • 12
    • 9544248690 scopus 로고    scopus 로고
    • Assessment of axilary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
    • Avril N, Dose J, Jänicke F et al. Assessment of axilary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Nat Cancer Inst 1996;88:1204-9.
    • (1996) J Nat Cancer Inst , vol.88 , pp. 1204-1209
    • Avril, N.1    Dose, J.2    Jänicke, F.3
  • 13
    • 33745115349 scopus 로고    scopus 로고
    • Fluodeoxyglucose positron emission tomography with sentinel node biopsy for evaluation of axillary involvement in breast cancer
    • Gil-Rendo A, Zornoza G, Garcia-Velloso MJ et al. Fluodeoxyglucose positron emission tomography with sentinel node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg 2006;93:707-12.
    • (2006) Br J Surg , vol.93 , pp. 707-712
    • Gil-Rendo, A.1    Zornoza, G.2    Garcia-Velloso, M.J.3
  • 14
    • 45849133028 scopus 로고    scopus 로고
    • Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDGPET/ CT) in combination with ultrasonography for axillary staging in primary breast cancer
    • Ueda S, Tsuda H, Asakawa H et al. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDGPET/ CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 2008;8:165-74.
    • (2008) BMC Cancer , vol.8 , pp. 165-174
    • Ueda, S.1    Tsuda, H.2    Asakawa, H.3
  • 15
    • 34249038610 scopus 로고    scopus 로고
    • Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management
    • Piperkova E, Raphael B, Altinyay M et al. Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management. Clin Nucl Med 2007;32:429-34.
    • (2007) Clin Nucl Med , vol.32 , pp. 429-434
    • Piperkova, E.1    Raphael, B.2    Altinyay, M.3
  • 16
    • 54249112913 scopus 로고    scopus 로고
    • Preoperative staging of large primary breast cancer with (18F)fluorodeoxyglucose positron emission tomography/computed tomography with conventional imaging procedures
    • Fuster D, Duch J, Paredes P et al. Preoperative staging of large primary breast cancer with (18F)fluorodeoxyglucose positron emission tomography/computed tomography with conventional imaging procedures. J Clin Oncol 2008;26:4746-51.
    • (2008) J Clin Oncol , vol.26 , pp. 4746-4751
    • Fuster, D.1    Duch, J.2    Paredes, P.3
  • 17
    • 48749083122 scopus 로고    scopus 로고
    • Breast cancer staging in a single session: Whole-body PET/CT mammography
    • Heusner TA, Kuemmel S, Umutlu L et al. Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 2008;49:1215-22.
    • (2008) J Nucl Med , vol.49 , pp. 1215-1222
    • Heusner, T.A.1    Kuemmel, S.2    Umutlu, L.3
  • 18
    • 65549136113 scopus 로고    scopus 로고
    • Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer
    • Chae BJ, Bae JS, Kang BJ et al. Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer. Jpn J Clin Oncol 2009;39:284-9.
    • (2009) Jpn J Clin Oncol , vol.39 , pp. 284-289
    • Chae, B.J.1    Bae, J.S.2    Kang, B.J.3
  • 19
    • 0029665874 scopus 로고    scopus 로고
    • Qualitative (18F)FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability
    • Scheidhauer K, Scharl A, Pietrzyk U et al. Qualitative (18F)FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med 1996;23:618-23.
    • (1996) Eur J Nucl Med , vol.23 , pp. 618-623
    • Scheidhauer, K.1    Scharl, A.2    Pietrzyk, U.3
  • 20
    • 46249125080 scopus 로고    scopus 로고
    • Comparison between positron emission tomography using 2-(fluorine-18)fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer
    • Mahner S, Schirrmacher S, Brenner W et al. Comparison between positron emission tomography using 2-(fluorine-18)fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 2008;19:1249-54.
    • (2008) Ann Oncol , vol.19 , pp. 1249-1254
    • Mahner, S.1    Schirrmacher, S.2    Brenner, W.3
  • 21
    • 33847657145 scopus 로고    scopus 로고
    • A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases
    • Veronesi U, De Cicco C, Galimberti VE et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2007;18:473-8.
    • (2007) Ann Oncol , vol.18 , pp. 473-478
    • Veronesi, U.1    de Cicco, C.2    Galimberti, V.E.3
  • 22
    • 58149387529 scopus 로고    scopus 로고
    • Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodoexyglucose positron emission tomography/ computed tomography fusion imaging
    • Taira N, Ohsumi S, Takabatake D et al. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodoexyglucose positron emission tomography/ computed tomography fusion imaging. Jpn J Clin Oncol 2009;39:16-21.
    • (2009) Jpn J Clin Oncol , vol.39 , pp. 16-21
    • Taira, N.1    Ohsumi, S.2    Takabatake, D.3
  • 23
    • 0035906212 scopus 로고    scopus 로고
    • Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-d-glucose-positron emission tomography: Clinical evaluation and alternative management
    • Greco M, Crippa F, Agresti R et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-d-glucose-positron emission tomography: clinical evaluation and alternative management. J Nat Can Inst 2001;93:630-5.
    • (2001) J Nat Can Inst , vol.93 , pp. 630-635
    • Greco, M.1    Crippa, F.2    Agresti, R.3
  • 24
    • 0031931680 scopus 로고    scopus 로고
    • Prospective evaluation of fluorine-18- fdg PET in presurgical staging of the axilla in breast cancer
    • Crippa F, Agresti R, Seregni E et al. Prospective evaluation of fluorine-18- fdg PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
    • (1998) J Nucl Med , vol.39 , pp. 4-8
    • Crippa, F.1    Agresti, R.2    Seregni, E.3
  • 25
    • 19244379204 scopus 로고    scopus 로고
    • Staging of the axilla in breast cancer, accurate in vivo assessment using positron emission tomography with 2- (fluorine-18)-fluoro-2-deoxy-D-glucose
    • Smith IC, Ogston KN, Whitford P et al. Staging of the axilla in breast cancer, accurate in vivo assessment using positron emission tomography with 2- (fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 1998;228:220-7.
    • (1998) Ann Surg , vol.228 , pp. 220-227
    • Smith, I.C.1    Ogston, K.N.2    Whitford, P.3
  • 26
    • 0031891569 scopus 로고    scopus 로고
    • Diagnostic value of positron emission tomography for detecting breast cancer
    • Noh DY, Yun IJ, Kim JS et al. Diagnostic value of positron emission tomography for detecting breast cancer. World J Surg 1998;22:223-8.
    • (1998) World J Surg , vol.22 , pp. 223-228
    • Noh, D.Y.1    Yun, I.J.2    Kim, J.S.3
  • 27
    • 0030984978 scopus 로고    scopus 로고
    • Axillary lymph node metastases: Screening with (F-18)2-deoxy-2-fluoro-D-glucose (FDG) PET
    • Adler LP, Faulhaber PF, Schnur KC et al: Axillary lymph node metastases: screening with (F-18)2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997;203:323-7.
    • (1997) Radiology , vol.203 , pp. 323-327
    • Adler, L.P.1    Faulhaber, P.F.2    Schnur, K.C.3
  • 28
    • 0141941538 scopus 로고    scopus 로고
    • Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases with early-stage breast cancer
    • Barranger E, Grahek D, Antoine M et al. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases with early-stage breast cancer. Ann Surg Oncol 2003;10:622-7.
    • (2003) Ann Surg Oncol , vol.10 , pp. 622-627
    • Barranger, E.1    Grahek, D.2    Antoine, M.3
  • 29
    • 20244364368 scopus 로고    scopus 로고
    • Fluorine-18 2-deoxy-2-fluoro- D-glucose PET in the preoperative staging of breast cancer: Comparison with the standard staging procedures
    • Schirrmeister H, Kühn T, Guhlmann A et al. Fluorine-18 2-deoxy-2-fluoro- D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351-8.
    • (2001) Eur J Nucl Med , vol.28 , pp. 351-358
    • Schirrmeister, H.1    Kühn, T.2    Guhlmann, A.3
  • 30
    • 0842323897 scopus 로고    scopus 로고
    • 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer
    • Zornoza G, Garcia-Velloso MJ, Sola J et al. 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer. Eur J Surg Oncol 2004;30:15-9.
    • (2004) Eur J Surg Oncol , vol.30 , pp. 15-19
    • Zornoza, G.1    Garcia-Velloso, M.J.2    Sola, J.3
  • 31
    • 1342311018 scopus 로고    scopus 로고
    • Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the Staging Breast Cancer With PET Study Group
    • Wahl RL, Siegel BA, Coleman E et al: Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the Staging Breast Cancer With PET Study Group. J Clin Oncol 2004;22:277-85.
    • (2004) J Clin Oncol , vol.22 , pp. 277-285
    • Wahl, R.L.1    Siegel, B.A.2    Coleman, E.3
  • 32
    • 0036775586 scopus 로고    scopus 로고
    • Pre-operative staging of invasive breast cancer with MR mammography and/or PET: Boon or bunk?
    • Rieber A, Schirrmeister H, Gabelmann A et al. Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? Br J Radiol 2002;75:789-98.
    • (2002) Br J Radiol , vol.75 , pp. 789-798
    • Rieber, A.1    Schirrmeister, H.2    Gabelmann, A.3
  • 33
    • 0034466373 scopus 로고    scopus 로고
    • Comparison of FDG-PET with MIBISPECT in the Detection of Breast Cancer and Axillary Lymph Node Metastasis
    • Yutani K, Shiba E, Kusuoka H et al. Comparison of FDG-PET with MIBISPECT in the Detection of Breast Cancer and Axillary Lymph Node Metastasis. J Comp Assist Tomography 2000;24:274-80.
    • (2000) J Comp Assist Tomography , vol.24 , pp. 274-280
    • Yutani, K.1    Shiba, E.2    Kusuoka, H.3
  • 34
    • 0000918158 scopus 로고    scopus 로고
    • The potential of F-18-FDG PET in breast cancer: Detection of primary lesions, axillary lymph node metastases, or distant metastases
    • Hubner KF, Smith GT, Thie JA et al. The potential of F-18-FDG PET in breast cancer: detection of primary lesions, axillary lymph node metastases, or distant metastases. Clin Pos Imaging 2000;3:197-205.
    • (2000) Clin Pos Imaging , vol.3 , pp. 197-205
    • Hubner, K.F.1    Smith, G.T.2    Thie, J.A.3
  • 35
    • 8944242605 scopus 로고    scopus 로고
    • Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose
    • Avril N, Dose J, Jänicke F et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 1996;14:1848-57.
    • (1996) J Clin Oncol , vol.14 , pp. 1848-1857
    • Avril, N.1    Dose, J.2    Jänicke, F.3
  • 36
    • 0029018271 scopus 로고
    • Positron emission tomography: 2- deoxy-2-(18F)-fluoro-D-glucose uptake in locally advanced breast cancers
    • Bruce DM, Evans NTS, Heys SD et al. Positron emission tomography: 2- deoxy-2-(18F)-fluoro-D-glucose uptake in locally advanced breast cancers. Eur J Surg Oncol 1995;21:280-3.
    • (1995) Eur J Surg Oncol , vol.21 , pp. 280-283
    • Bruce, D.M.1    Evans, N.T.S.2    Heys, S.D.3
  • 37
    • 0027243678 scopus 로고
    • Evaluation of breast masses and axillary lymph nodes with (18F) 2-deoxy-2-fluoro-D-glucose PET
    • Adler LP, Crowe JP, Al-Kaisi NK et al. Evaluation of breast masses and axillary lymph nodes with (18F) 2-deoxy-2-fluoro-D-glucose PET. Radiol 1993;87:743-50.
    • (1993) Radiol , vol.87 , pp. 743-750
    • Adler, L.P.1    Crowe, J.P.2    Al-Kaisi, N.K.3
  • 38
    • 0027743430 scopus 로고
    • Positron emission tomography of glucose metabolism in breast cancer
    • Nieweg OE, Wong WH, Singletary SE et al. Positron emission tomography of glucose metabolism in breast cancer. Ann New York Acad Sci 1993;698:423-8.
    • (1993) Ann New York Acad Sci , vol.698 , pp. 423-428
    • Nieweg, O.E.1    Wong, W.H.2    Singletary, S.E.3
  • 39
    • 0026696587 scopus 로고
    • The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease
    • Tse NY, Hoh CK, Hawkins RA et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 1992;216:27-34.
    • (1992) Ann Surg , vol.216 , pp. 27-34
    • Tse, N.Y.1    Hoh, C.K.2    Hawkins, R.A.3
  • 40
    • 33747598248 scopus 로고    scopus 로고
    • Preoperative FDG-PET for axillary metastases in patients with breast cancer
    • Chung A, Liou D, Karlan S et al. Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg 2006; 141:783-9.
    • (2006) Arch Surg , vol.141 , pp. 783-789
    • Chung, A.1    Liou, D.2    Karlan, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.